Immune checkpoint inhibitors for the treatment of unresectable stage iii non–small cell lung cancer: Emerging mechanisms and perspectives

Hiroyuki Inoue, Isamu Okamoto

Research output: Contribution to journalReview article

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Immune checkpoint inhibitors for the treatment of unresectable stage iii non–small cell lung cancer: Emerging mechanisms and perspectives'. Together they form a unique fingerprint.

Medicine & Life Sciences